Home BP Monitoring
1 other identifier
interventional
750
1 country
1
Brief Summary
Most cases of high blood pressure in teens are missed for a number of reasons. One reason is that the most common way to make a diagnosis is to make three or more blood pressure measurements in a doctor's office on separate days. This can be inconvenient. Also, measuring blood pressure in the office might be inaccurate, since children (including teens) might have high values in the office but normal values at home. For these reasons, investigators wish to study a different way to identify teens with high blood pressure. Home BP measurements have been used in Europe to make a diagnosis, but not yet in the United States, and never in a higher risk population of teens. African American teens are at higher risk for high blood pressure than other teens. Investigators will compare the values received from the home BP machines to another method (24 hour ambulatory BP monitoring or ABPM) which is the best standard for diagnosis. Investigators also want to learn more about participants experience and their child's experience with both methods. A small sample of participating teens and parents will be invited to participate in short telephone interviews. This study plans to enroll a total of 750 teens at UH. Recruitment will not take place from other organizations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2022
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
December 10, 2025
December 1, 2025
3 years
September 20, 2022
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Number of participants who meet criteria for hypertension based on average home BP reading.
Up to 2 weeks
Number of participants who meet criteria for hypertension based on 24-hour ambulatory BP reading.
Up to 24 hours
Percent agreement between home BP-reading based diagnosis versus 24-hour ABPM
Up to 2 weeks
True positive rate -- Number of home bp positives over ABPM positives
Up to 2 weeks
True negative rate -- Number of home bp negatives over ABPM negatives
Up to 2 weeks
Secondary Outcomes (2)
Number of subjects who complete home BP protocol
Up to 2 weeks
Number of subjects who complete both home BP verus 24-hour ABPM protocols
Up to 3 weeks
Study Arms (2)
Home Blood Pressure Machine
ACTIVE COMPARATORParticipants will be asked to measure blood pressure twice daily for three days in a row.
24-Hour Blood Pressure Machine
EXPERIMENTALParticipants will be asked to wear this machine for 24 hours.
Interventions
Participants will be asked to wear the machine for 24 hours.
Participants will be asked to measure blood pressure twice daily for three days in a row at home.
Eligibility Criteria
You may qualify if:
- Self-identify or identified by a parent as African-American or of partly African American ancestry
You may not qualify if:
- Prior hypertension diagnosis
- Prescribed BP medication
- History of congenital heart disease
- History of solid organ transplant
- Prescribed and using stimulants and other medications on a regular basis known to raise blood pressure such as testosterone and nicotine replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rao Goutham, MD
University Hospitals Cleveland Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman, Department of Family Medicine and Community Health
Study Record Dates
First Submitted
September 20, 2022
First Posted
September 23, 2022
Study Start
October 1, 2023
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
December 10, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share